Evidence map›Paper›PMID 22987878›Full record

ArticlePediatrics2012

Variability of growth in children starting antiretroviral treatment in southern Africa.

Thomas Gsponer, Ralf Weigel, Mary-Ann Davies, Carolyn Bolton, Harry Moultrie, Paula Vaz, Helena Rabie, Karl Technau, James Ndirangu, Brian Eley and 7 more

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Update: Vitamin DTrials · 2024
    Article
  6. Surgical implications of HIV infection.Pediatric surgery international · 2022
    Review
  7. Vitamin DTrials · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis With Antiretroviral Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  15. Chronic Morbidity Among Older Children and Adolescents at Diagnosis of HIV Infection.Journal of acquired immune deficiency syndromes (1999) · 2016
    Article
  16. Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2016
    Article
  17. Article
  18. Observational
  19. Getting to 90-90-90 in paediatric HIV: What is needed?Journal of the International AIDS Society · 2015
    Article
  20. Targeting 90-90-90--don't leave children and adolescents behind.Journal of the International AIDS Society · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 8 countries.

Thomas GsponerInstitute of Social and Preventive Medicine (ISPM), University of Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland.
Ralf Weigel
Mary-Ann Davies
Carolyn Bolton
Harry Moultrie
Paula Vaz
Helena Rabie
Karl Technau
James Ndirangu
Brian Eley
Daniela Garone
Maureen Wellington
Janet Giddy
Jochen Ehmer
Matthias Egger
Olivia Keiser
IeDEA Southern Africa
Institute of Social and Preventive Medicine · CHUniversity of Cape Town · ZAUniversity of the Witwatersrand · ZALiverpool School of Tropical Medicine · GBMaputo Central Hospital · MZMcCord Hospital · ZAMédecins Sans Frontières · ZAStellenbosch University · ZAUniversity of Alabama at Birmingham · USUniversity of Bern · CHUniversity of KwaZulu-Natal · ZAZimbabwe National Quality Assurance Program · ZW

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
NIAID NIH HHS 5U01-AI069924-05NIAID NIH HHS U01 AI069924Wellcome Trust 097410
6 · The paper itself

Abstract

backgroundPoor growth is an indication for antiretroviral therapy (ART) and a criterion for treatment failure. We examined variability in growth response to ART in 12 programs in Malawi, Zambia, Zimbabwe, Mozambique, and South Africa.

methodsTreatment naïve children aged <10 years were included. We calculated weight for age z scores (WAZs), height for age z scores (HAZs), and weight for height z scores (WHZs) up to 3 years after starting ART, by using the World Health Organization standards. Multilevel regression models were used.

resultsA total of 17990 children (range, 238-8975) were followed for 36181 person-years. At ART initiation, most children were underweight (50%) and stunted (66%). Lower baseline WAZ, HAZ, and WHZ were the most important determinants of faster catch-up growth on ART. WAZ and WHZ increased rapidly in the first year and stagnated or reversed thereafter, whereas HAZ increased continuously over time. Three years after starting ART, WAZ ranged from -2.80 (95% confidence interval [CI]: -3.66 to -2.02) to -1.98 (95% CI: -2.41 to -1.48) in children with a baseline z score < -3 and from -0.79 (95% CI: -1.62 to 0.02) to 0.05 (95% CI: -0.42 to 0.51) in children with a baseline WAZ ≥ -1. For HAZ, the corresponding range was -2.33 (95% CI: -2.62 to -2.02) to -1.27 (95% CI: -1.58 to -1.00) for baseline HAZ < -3 and -0.24 (95% CI: -0.56 to 0.15) to 0.84 (95% CI: 0.53 to 1.16) for HAZ ≥ -1.

conclusionsDespite a sustained growth response and catch-up growth in children with advanced HIV disease treated with ART, normal weights and heights are not achieved over 3 years of ART.

Indexed as

Africa, SouthernAnti-HIV AgentsChildChild, PreschoolFemaleFollow-Up StudiesGrowthGrowth DisordersHIV InfectionsHumansMaleModels, StatisticalRegression AnalysisThinnessTreatment OutcomeAnti-HIV Agents

Identifiers

PMID22987878
PMCPMC3457616
OpenAlexW2110596103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.